BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/14/2026 4:49:28 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-08-29 05:09 |
|
Peer-Review Started |
|
2025-08-29 05:09 |
|
First Decision by Editorial Office Director |
|
2025-10-13 08:52 |
|
Return for Revision |
|
2025-10-13 08:52 |
|
Revised |
|
2025-10-27 17:23 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-01-07 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-07 11:13 |
|
Articles in Press |
|
2026-01-07 11:13 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-11 02:09 |
|
Publish the Manuscript Online |
|
2026-03-14 04:49 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Health Care Sciences & Services |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nathan Kleinman, Tejas Desai and Charuhas Thakar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nathan Kleinman, PhD, Department of Data Analysis and Research, Kleinman Analytic Solutions, LLC., 405 Cool Valley Dr., Paso Robles, CA 93446, United States. nathan@kleinmansolutions.com |
| Key Words |
Renin-angiotensin aldosterone system inhibitors; Patiromer; Adherence; Hyperkalemia; Proportion of days covered |
| Core Tip |
Increased use and optimal dosing of guideline-recommended renin-angiotensin aldosterone system inhibitors (RAASi) improve patient outcomes in patients with heart failure, chronic kidney disease, and diabetes. However, RAASi use is also associated with increased occurrence of high potassium levels (hyperkalemia). Patiromer is indicated for the treatment of hyperkalemia, and patients taking patiromer are better able to tolerate optimal doses of RAASi than patients not taking patiromer. In this United States study from 2014 to 2019, 3323 patients who were more adherent with patiromer proportion of days covered > 80% used more RAASi than 10124 patients who were less adherent with patiromer (proportion of days covered ≤ 80%). |
| Publish Date |
2026-03-14 04:49 |
| Citation |
Kleinman N, Desai T, Thakar C. Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study. World J Nephrol 2026; 15(1): 113599 |
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i1/113599.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v15.i1.113599 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
